Top 50 Chemical Manufacturing in Belgium

Syensqo develops chemical solvents tailored for industries such as aerospace, automotive, food, and agriculture, focusing on enhancing operational efficiency and sustainability. Their products address the need for environmentally friendly solutions that minimize harmful emissions and improve safety in industrial applications.

AmphiStar develops, scales up, and produces high-performance biosurfactants derived entirely from biobased waste and side streams. These biocompatible ingredients serve diverse markets including home care, personal care, industrial cleaners, textiles, and agrochemicals. The company utilizes patented technology to deliver uniform, pure, and sustainable surfactant solutions that support a circular economy.

The startup develops hydrogen panels that generate hydrogen gas by utilizing solar energy to split water molecules, capturing moisture from the air. This technology provides a sustainable energy source at a lower cost, complementing traditional solar panels and addressing the need for clean energy alternatives.

9ID provides a unified platform for digitizing workforce and contractor compliance management across multiple sites. The system automates verification processes, ensuring workers arrive site-ready with verified credentials and documentation. This centralization eliminates manual chaos, speeds up gate access, and maintains real-time audit readiness.

Exothera is a contract development and manufacturing organization (CDMO) specializing in GMP manufacturing services for viral vectors and RNA therapeutics, utilizing fixed bed and stirred tank bioprocessing technologies. The company addresses the need for efficient and scalable production solutions in the development of vaccines and gene therapies, ensuring high yields and quality from pre-clinical stages to commercial readiness.

The startup provides customized infrastructure solutions, including clean rooms, laboratories, and logistics support, specifically designed for pharmaceutical and biotech companies. This enables clients to conduct product development in controlled environments that meet stringent regulatory standards, ensuring product integrity and safety.

SIMABS NV has developed a continuous bioprocessing platform for the rapid and cost-effective development and GMP manufacturing of monoclonal and bispecific antibodies, addressing the need for high-quality biologics in personalized medicine. Their integrated approach offers a complete solution, including cell line development and regulatory support, enabling biopharmaceutical companies to accelerate their product development timelines while reducing costs.

PanTera focuses on enabling personalized tumor treatment through radiopharmaceuticals by securing the large-scale production of actinium-225 (Ac-225). This alpha-emitting radioisotope is essential for Targeted RadioTherapy (TRT) applications in oncology. The company's efforts aim to increase the accessibility of innovative cancer therapies based on Ac-225 and theranostics.

Unizima establishes regional bioproduction facilities in low-income nations to manufacture biologics like vaccines and monoclonal antibodies, integrating these with local healthcare systems. This approach addresses the lack of access to essential medicines in emerging markets by providing affordable, locally produced biologics and skilled workforce training.

The startup manufactures machines that utilize mechanical resonance properties to clean diesel particulate filters, extending the lifespan of diesel engines in the automotive industry. This technology addresses the issue of filter clogging, which can lead to increased maintenance costs and reduced vehicle performance.

Aphea.Bio develops natural biocontrol and biostimulant products for agriculture using its APEXbio™ R&D platform. This platform accelerates the discovery of novel microbial solutions for crop protection and enhancement. The company provides advanced biological products, including biostimulants and biofungicides, supporting sustainable farming practices.

Solithor develops all-solid-state lithium battery technology specifically designed for the electromobility sector, focusing on applications in aviation, urban air mobility, and aerospace. Their batteries offer enhanced safety, higher energy density, and improved thermal stability, addressing the critical need for reliable and environmentally friendly energy storage solutions in transportation.

ATB Therapeutics develops targeted antibody therapies using its proprietary antibody payload technology to treat hematological malignancies and autoimmune diseases. The company addresses the need for effective treatments in oncology and autoimmune disorders by leveraging a plant-based manufacturing platform to enhance therapeutic delivery.

This company provides an integrated software suite for additive manufacturing, covering design, build preparation, simulation, and inspection. Their Manufacturing OS enhances production automation, machine utilization, and traceability across the entire additive workflow. The platform also includes AI-powered monitoring to detect anomalies in real-time and a digital warehouse for managing certified spare parts.

This company develops and deploys modular Direct Air Capture (DAC) technology utilizing solid sorbents to remove atmospheric CO2. The captured carbon dioxide is permanently sequestered through underground mineralization into rock formations. Sirona provides certified, high-quality carbon removal credits for enterprises seeking to meet climate objectives.

Materialise provides a technology‑neutral digital manufacturing platform that combines software tools (Magics, Mimics, Phits Suite, Footscan) for CAD and medical image preparation, simulation, and automated build validation with a global network of high‑capacity 3D‑printing facilities. The cloud‑based workflow enables engineers, clinicians, and researchers to produce rapid prototypes, low‑volume series, and mass‑customized parts while maintaining traceability, regulatory compliance, and integration with PLM, ERP, or EHR systems. Sustainability features monitor material and energy use to reduce waste.

OneLIFE develops patented enzymatic cleaning solutions that effectively dissolve bacterial biofilms on medical devices, ensuring thorough decontamination and reducing the risk of healthcare-associated infections. Their technology addresses the challenge of biofilm contamination, which can render medical devices ineffective and contribute to antibiotic resistance.

Ziphius develops a self-amplifying RNA (saRNA) platform for the rapid and scalable manufacturing of innovative medical tools addressing public health needs. This platform utilizes proprietary Lipid Nanoparticles (LNP) optimized for saRNA delivery, stability, and various administration routes. The technology aims to deliver higher protein expression at lower dosages for applications spanning infectious disease vaccines, rare disease therapies, and oncology treatments.

Voredos SRL provides algorithmic solutions for analyzing large datasets in biology, biotechnology, and chemistry. Their technology enhances data processing efficiency, enabling researchers to derive actionable insights from complex biological and chemical data.

PowerNavigator is an AI-powered platform that provides full probability distributions for energy price, load, and renewables generation forecasts. It enables companies without dedicated risk desks to hedge against price volatility and optimize energy procurement strategies. The platform offers custom forecasts and flexible data access via dashboards and API to support smarter trading decisions.

EXO Biologics develops biopharmaceuticals using extracellular vesicles (EVs) to create therapies for rare inflammatory diseases that do not respond to standard treatments. Their proprietary drug loading and delivery platform enhances the therapeutic potential of EVs, providing a safer and more consistent alternative to traditional cell-based therapies.

MRM Health develops therapeutics using its proprietary CORAL® platform, which combines selected bacterial strains into optimized consortia manufactured as a single drug substance. This approach addresses the challenges of engraftment and efficacy in microbiome-based therapies, particularly for inflammatory bowel diseases and other conditions.

REUP Technologies utilizes proprietary recycling technology to convert a diverse range of textile waste, including polycotton, into high-quality Next-Gen Cotton and Next-Gen Polyester. This process addresses the significant issue of textile waste in landfills by providing sustainable raw materials that match the performance and cost of traditional fibers.

The startup specializes in developing proprietary formulations for specialty pharmaceuticals targeting bone health, immunity, and respiratory conditions. By optimizing therapy outcomes, the company enables patients in underserved markets to access effective treatments that are tailored to their specific health needs.

Grounds Up transforms discarded coffee grounds into valuable raw materials through a process of upcycling, which includes decontamination, drying, and extraction of coffee oil and press cake. This approach addresses the annual disposal of 67,000 tonnes of coffee waste in Belgium, significantly reducing CO2 emissions and contributing to a circular economy.

This company develops and supplies heavy-metal-free quantum dot (QD) materials, including inkjet inks, dispersions, and resins, for advanced color conversion applications. Their QustomJet™ inks enable high-performance, wide-gamut, and energy-efficient displays across microLED, miniLED, and OLED technologies. They offer customized QD formulations tailored for specific manufacturing processes and high-resolution patterning requirements.

Quantoom Biosciences develops a proprietary RNA manufacturing technology, Ntensify, which enables scalable mRNA production for drug substances and formulated products. Their solutions address the need for efficient and compliant mRNA bioproduction in drug discovery, pre-clinical research, and clinical trials.

This company manages plastic waste by collecting PET, HDPE, and LDPE plastics through a network of collectors in Cameroon. The collected materials are sorted, washed, and processed into flakes and PET straps. These recycled raw materials are then sold locally and internationally to support a circular economy.

This company produces premium-grade glycan building blocks and enzymes using cell-free enzymatic synthesis. They provide scalable access to high-value activated sugars and complex HMOs for R&D and industrial applications. Their offerings support advancements in biopharmaceuticals, ADCs, and next-generation nutrition products.

The startup manufactures industrial smart glasses that utilize smartphone processing power to provide hands-free remote assistance and workflow guidance without the radiation risk associated with traditional devices. This technology enables industrial sites and corporate clients to implement live-streaming capabilities and reduce deployment costs effectively.

Azumuta provides a comprehensive software platform designed to digitize the factory shop floor and eliminate paper-based processes. The platform integrates modules for Manufacturing Execution Systems (MES), digital work instructions, quality assurance, and skill matrix management. This centralization of shop floor data and workflows enables manufacturers to improve operational efficiency, ensure compliance, and capture real-time production insights.

The startup offers concentrated cleaning solutions and solid strips that dissolve in water, replacing traditional liquid cleaners and eliminating single‑use plastic bottles. Products are packaged in lightweight, plant‑based biodegradable containers and shipped carbon‑neutral, with a subscription refill service that ensures continuous supply while reducing waste and transportation emissions.

The startup develops standalone contactless three-dimensional sensor technology that provides real-time visualization of picking and assembly instructions in a superimposed environment. This technology enhances operational efficiency in manufacturing by minimizing human errors and ensuring qualitative performance.

B4Plastics specializes in the development and production of biopolymers using bio-based building blocks, enabling the creation of customized biomaterials for various applications. The company addresses the need for sustainable plastic alternatives by offering scalable solutions from research and development to bulk production and licensing.

Proceedix offers an AI-powered Connected Worker platform designed for industrial manufacturing environments. This platform unifies data to deliver digital work instructions, guided inspections, and skills training directly to frontline personnel. The system enhances operational insights, ensures compliance through detailed audit trails, and boosts worker productivity via persona-based industrial AI Copilots.

The startup manufactures a fiber-strengthened carbon composite material that combines carbon composites with specially developed steel fibers to enhance impact resistance while maintaining low weight and high stiffness. This technology enables the production of durable and lightweight bicycle frames, providing cyclists with improved safety and longevity.

The startup utilizes genetically modified Black Soldier Flies (Hermetia illucens) to produce human insulin and other recombinant proteins at scale, significantly reducing the cost of growth media for cultivated meat. Additionally, the company offers genetic modification services tailored for the global BSF industry, enhancing production efficiency and sustainability.

BelGaN manufactures gallium nitride (GaN) semiconductors for automotive, industrial, and medical applications, focusing on high-efficiency power conversion and miniaturization. The company addresses the need for energy-efficient electronic systems that reduce energy waste and support the transition to a carbon-neutral society.

This company operates the leading marketplace for industrial automation, connecting buyers with trusted robot suppliers and integrators. They streamline the procurement process by offering expert consultation to define needs and delivering three comparable quotes for robotics projects within one week. The platform facilitates discovery of products like cobots, mobile robots, and turnkey solutions across various automation categories.

The startup provides integrated permeate channels utilizing washable flat sheet membranes that enhance fouling control and improve filtration flux. This technology enables industries and municipalities to efficiently reuse wastewater, addressing the challenges of membrane fouling in filtration systems.

Effex provides a SaaS platform for Design of Experiments (DoE) that minimizes experimental effort while maximizing knowledge discovery. The software delivers optimal experimental designs, including proprietary OMARS designs, tailored for specific process improvement challenges. This approach reduces resource consumption, accelerates time-to-market, and facilitates the discovery of best operating conditions and factor interactions.

ARK Capture Solutions develops a breakthrough, full-electric hybrid technology for point source carbon capture. This solution offers low capture costs and record low energy consumption, specifically targeting industrial flue gases with low CO2 concentrations. The modular system enables autonomous operation without chemistry or hazardous materials, addressing a significant segment of global industrial emissions.

The startup develops bioherbicides derived from essential oils to provide an environmentally friendly alternative to synthetic herbicides. Their products enable effective weed control in agricultural fields and gardens, promoting sustainable farming practices without harmful chemical residues.

Zymofix produces high-quality beneficial microorganisms for agriculture by fermenting biomass residues, enabling large-scale and cost-effective manufacturing. This approach addresses the high costs and resource consumption associated with traditional microbial production methods, promoting sustainable agricultural practices and environmental health.

VOCSens develops self-calibrating, ultra-low-power multi-gas microsensors using patented CMOSEnvi™ technology, enabling precise measurement of various gases and volatile organic compounds (VOCs) for diverse industries. Their EnviCam® product line helps businesses meet regulatory compliance and enhance environmental safety by providing accurate gas concentration data.

Pozyx develops a hardware and software platform that utilizes ultra-wideband (UWB) and Bluetooth (BLE) technologies for precise indoor and outdoor asset tracking, achieving location accuracy of up to 10 cm. The platform addresses the challenges of lost assets and inefficient inventory management in logistics and manufacturing by providing real-time visibility and actionable insights into material flows and equipment utilization.

Deep LS GmbH offers computational solutions to accelerate drug discovery and development for pharmaceutical and biopharmaceutical companies. Their platform utilizes machine learning to identify potential drug molecules, optimize their properties like solubility and ADME, and pinpoint binding sites on targets.

DeuterOncology is developing DO-2, a deuterated MET kinase inhibitor designed to enhance the efficacy and tolerability of targeted therapies for MET-driven lung cancer. This compound aims to reduce metabolic liabilities and improve drug exposure at lower doses, addressing the limitations of existing MET inhibitors in oncology treatments.

Twintag provides a scalable DataOps platform that utilizes unique identifiers to create digital twins for physical products, enabling real-time data access and management across the supply chain. This technology enhances product lifecycle management, compliance with regulations, and customer engagement by facilitating circularity initiatives and optimizing return and repair processes.

The startup develops hypoxia-activated prodrugs (HAPs) that enhance the efficacy of conventional anti-cancer treatments by targeting the tumor microenvironment. This approach enables physicians to provide more effective and well-tolerated therapies for cancer patients, improving treatment outcomes and patient quality of life.